A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells

Journal of Immunology

Volumn 177, Issue 10, 2006, Pages 7211-7224

  Kim, Kyoung S ^a   Rajagopal, Vikram ^a   Gonsalves, Caryn ^a   Johnson, Cage ^a   Kalra, Vijay K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 3 [2 [4 (4,4' DIFLUOROBENZHYDRYLIDENE)PIPERIDINO]ETHYL] 2,3 DIHYDRO 2 THIOXO 4(1H) QUINAZOLINONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COBALT CHLORIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OXYGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BINDING SITE; BLOOD VESSEL OCCLUSION; CELL CULTURE; CELL LINE; CHEMOTAXIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HEART INFARCTION; HUMAN; HUMAN CELL; HYPOXEMIA; HYPOXIA; INFLAMMATION; LEUKOCYTE; LUNG BLOOD VESSEL; LUNG INJURY; NEUTROPHIL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SICKLE CELL ANEMIA; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VASCULAR ENDOTHELIUM;

EID: 33750802140     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.10.7211     Document Type: Article

References (44)

1. Kaul, D. K., M. E. Fabry, and R. L. Nagel. 1996. The pathophysiology of vascular obstruction in the sickle syndromes. Blood Rev. 10: 29-44.
2. Wun, T. 2001. The role of inflammation and leukocytes in the pathogenesis of sickle cell disease; haemoglobinopathy. Hematology 5: 403-412.
3. Wun, T., M. Cordoba, A. Rangaswami, A. W. Cheung, and T. Paglieroni. 2002. Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease. Clin. Lab. Haematol. 24: 81-88.
4. Platt, O. S. 2000. Sickle cell anemia as an inflammatory disease. J. Clin. Invest. 106: 337-338.
5. Belcher, J. D., H. Mahaseth, T. E. Welch, A. E. Vilback, K. M. Sonbol, V. S. Kalambur, P. R. Bowlin, J. C. Bischof, R. P. Hebbel, and G. M. Vercellotti. 2005. Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. Am. J. Physiol. 288: H2715-H2725.
6. 1-Integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood 82: 1891-1899.
7. Gee, B. E., and O. S. Platt. 1995. Sickle reticulocytes adhere to VCAM-1. Blood 85: 268-274.
8. Sultana, C., Y. Shen, V. Rattan, C. Johnson, and V. K. Kalra. 1998. Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes. Blood 92: 3924-3935.
9. Matsui, N. M., L. Borsig, S. D. Rosen, M. Yaghmai, A. Varki, and S. H. Embury. 2001. P-selectin mediates the adhesion of sickle erythrocytes to the endothelium. Blood 98: 1955-1962.
10. Vichinsky, E. P., L. A. Styles, L. H. Colangelo, E. C. Wright, O. Castro, and B. Nickerson. 1997. Acute chest syndrome in sickle cell disease: clinical presentation and course: Cooperative Study of Sickle Cell Disease. Blood 89: 1787-1792.
11. Stuart, M. J., and B. N. Setty. 1999. Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Blood 94: 1555-60.
12. Setty, B. N. Y., M. J. Stuart, C. Dampier, D. Brodecki, and J. L. Allen. 2003. Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet 362: 1450-1455.
13. Perelman, N., S. K. Selvaraj, S. Batra, L. R. Luck, A. Erdreich-Epstein, T. D. Coates, V. K. Kalra, and P. Malik. 2003. Placenta growth factor activates monocytes and correlates with sickle cell disease severity. Blood 102: 1506-1514.
14. Selvaraj, S. K., R. K. Giri, N. Perelman, C. Johnson, P. Malik, and V. K. Kalra. 2003. Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 102: 1515-1524.
15. Vichinsky, E. P., L. D. Neumayr, A. N. Earles, R. Williams, E. T. Lennette, D. Dean, B. Nickerson, E. Orringer, V. McKie, R. Bellevue, et al. 2000. Causes and outcomes of the acute chest syndrome in sickle cell disease: National Acute Chest Syndrome Study Group. N. Engl. J. Med. 342: 1855-1865.
16. Yoshida, N., D. N. Granger, D. C. Anderson, R. Rothlein, C. Lane, and P. R. Kvietys. 1992. Anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Am. J. Physiol. 262: H1891-H1898.
17. De Franceschi, L., A. Baron, A. Scarpa, C. Adrie, A. Janin, S. Barbi, J. Kister, P. Rouyer-Fessard, R. Corrocher, P. Leboulch, and Y. Beuzard. 2003. Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation. Blood 102: 1087-1096.
18. Solovey, A., R. Kollander, A. Shet, L. C. Milbauer, S. Choong, A. Panoskaltsis-Mortari, B. R. Blazar, R. J. Kelm, Jr., and R. P. Hebbel. 2004. Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin. Blood 104: 840-846.
19. Semenza, G. L. 2002. Signal transduction to hypoxia-inducible factor 1. Biochem. Pharmacol. 64: 993-998.
20. Wenger, R. H. 2000. Mammalian oxygen sensing, signalling and gene regulation. J. Exp. Biol. 203: 1253-1263.
21. Goldberg, M. A., S. P. Dunning, and H. F. Bunn. 1988. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 242: 1412-1415.
22. Goldberg, M. A., and T. J. Schneider. 1994. Similarities between the oxygensensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269: 4355-4359.
23. Goldwasser, E., P. Alibali, and A. Gardner. 1995. Differential inhibition by iodonium compounds of induced erythropoietin expression. J. Biol. Chem. 270: 2628-2629.
24. Ockaili, R., R. Natarajan, F. Salloum, B. J. Fisher, D. Jones, A. A. Fowler III, and R. C. Kukreja. 2005. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. Am. J. Physiol. 289: H542-H548.
25. Appelhoff, R. J., Y. M. Tian, R. R. Raval, H. Turley, A. L. Harris, C. W. Pugh, P. J. Ratcliffe, and J. M. Gleadle. 2004. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279: 38458-38465.
26. Hanze, J., B. G. Eul, R. Savai, S. Krick, P. Goyal, F. Grimminger, W. Seeger, and F. Rose. 2003. RNA interference for HIF-1α inhibits its downstream signalling and affects cellular proliferation. Biochem. Biophys. Res. Commun. 312: 571-577.
27. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475-1489.
28. Lim, W., W. Ma, K. Gee, S. Aucoin, D. Nandan, F. Diaz-Mitoma, M. Kozlowski, and A. Kumar. 2002. Distinct role of p38 and c-Jun N-terminal kinases in IL-10-dependent and IL-10-independent regulation of the costimulatory molecule B7.2 in lipopolysaccharide-stimulated human monocytic cells. J. Immunol. 168: 1759-1769.
29. Zhao, D., A. C. Keates, S. Kuhnt-Moore, M. P. Moyer, C. P. Kelly, and C. Pothoulakis. 2001. Signal transduction pathways mediating neurotensin-stimulated interleukin-8 expression in human colonocytes. J. Biol. Chem. 276: 44464-44471.
30. Reddy, K. V., K. J. Serio, C. R. Hodulik, and T. D. Bigby. 2003. 5-Lipoxygenase-activating protein gene expression: key role of CCAAT/enhancer-binding proteins (C/EBP) in constitutive and tumor necrosis factor (TNF) α-induced expression in THP-1 cells. J. Biol. Chem. 278: 13810-13818.
31. Francis, R. B., Jr., and L. J. Haywood. 1992. Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease. J. Natl. Med. Assoc. 84: 611-615.
32. Croizat, H. 1994. Circulating cytokines in sickle cell patients during steady state. Br. J. Haematol. 87: 592-597.
33. Duits, A. J., J. B. Schnog, L. R. Lard, A. W. Saleh, and R. A. Rojer. 1998. Elevated IL-8 levels during sickle cell crisis. Eur. J. Haematol. 61: 302-305.
34. Giri, R. K., S. K. Selvaraj, and V. K. Kalra. 2003. Amyloid peptide-induced cytokine and chemokine expression in THP-1 monocytes is blocked by small inhibitory RNA duplexes for early growth response-1 messenger RNA. J. Immunol 170: 5281-5294.
35. Zundel, W., C. Schindler, D. Haas-Kogan, A. Koong, F. Kaper, E. Chen, A. R. Gottschalk, H. E. Ryan, R. S. Johnson, A. B. Jefferson, et al. 2000. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14: 391-396.
36. Mukaida, N., M. Shiroo, and K. Matsushima. 1989. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J. Immunol. 143: 1366-1371.
37. Temes, E., S. Martin-Puig, B. Acosta-Iborra, M. C. Castellanos, M. Feijoo-Cuaresma, G. Olmos, J. Aragones, and M. O. Landazuri. 2005. Activation of HIF-prolyl hydroxylases by R59949, an inhibitor of the diacylglycerol kinase. J. Biol. Chem. 280: 24238-24244.
38. Hunninghake, G. W., J. E. Gadek, H. M. Fales, and R. G. Crystal. 1980. Human alveolar macrophage-derived chemotactic factor for neutrophils: stimuli and partial characterization. J. Clin. Invest. 66: 473-483.
39. Strieter R. M., S. L. Kunkel, H. J. Showell, D. G. Remick, S. H. Phan, P. A. Ward, and R. M. Marks. 1989. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β. Science 243: 1467-1469.
40. Nakamura, H., K. Yoshimura, H. A. Jaffe, and R. G. Crystal. 1991. Interleukin-8 gene expression in human bronchial epithelial cells. J. Biol. Chem. 266: 19611-19617.
41. Liu, Q., U. Moller, D. Flugel, and T. Kietzmann. 2004. Induction of plasminogen activator inhibitor I gene expression by intracellular calcium via hypoxia-inducible factor-1. Blood 104: 3993-4001.
42. Barchowsky, A., N. V. Soucy, K. A. O'Hara, J. Hwa, T. L. Noreault, and A. S. Andrew, 2002. A novel pathway for nickel-induced interleukin-8 expression. J. Biol. Chem. 277: 24225-24231.
43. Mukaida, N. 2003. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am. J. Physiol. 284: L566-L577.
44. Andrew, A. S., L. R. Klei, and A. Barchowsky. 2001. Nickel requires hypoxia-inducible factor-1α, not redox signaling, to induce plasminogen activator inhibitor-1. Am. J. Physiol. 281: L607-L615.